Author:
Liu Ying,Qi Yang,Bai Zhi-hui,Ni Chen-xu,Ren Qi-hui,Xu Wei-heng,Xu Jing,Hu Hong-gang,Qiu Lei,Li Jian-zhong,He Zhi-gao,Zhang Jun-ping
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference40 articles.
1. Ferrin G, Aguilar-Melero P, Rodriguez-Peralvarez M, Montero-Alvarez JL, de la Mata M . Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepatic Med 2015; 7: 1–10.
2. El-Serag HB, Siegel AB, Davila JA, Shaib YH, Cayton-Woody M, McBride R, et al. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol 2006; 44: 158–66.
3. Davila JA, Duan Z, McGlynn KA, El-Serag HB . Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol 2012; 46: 71–7.
4. Thomas MB, O'Beirne JP, Furuse J, Chan AT, Abou-Alfa G, Johnson P . Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol 2008; 15: 1008–14.
5. Reya T, Morrison SJ, Clarke MF, Weissman IL . Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105–11.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献